TITLE

Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization

AUTHOR(S)
Zhang, Yingjie; Liu, Qiqi; Wang, Dou; Chen, Suhong; Wang, Shengqi
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Presently, the resistance of Influenza A virus isolates causes great difficulty for the prevention and treatment of influenza A virus infection. It is important to establish a drug-resistance detection method for epidemiological study and personalized medicine in the clinical setting. Consequently, a cost-effective oligonucleotide microarray visualization method, which was based on quantum dot-catalyzed silver deposition, was developed and evaluated for the simultaneous detection of neuraminidase H275Y and E119V; matrix protein 2 V27A and S31N mutations of influenza A (H3N2), seasonal influenza A (H1N1), and 2009 influenza A (H1N1). Then, 307 clinical throat swab specimens were detected and the drug-resistance results showed that 100% (17/17) of influenza A (H3N2) and 100% (259/259) of 2009 influenza A (H1N1) samples were resistant to amantadine and susceptible to oseltamivir; and 100% (5/5) of seasonal influenza A (H1N1) samples were resistant to both amantadine and oseltamivir.
ACCESSION #
87625245

 

Related Articles

  • Treatment of Immunocompromised, Critically Ill Patients with Influenza A H1N1 Infection with a Combination of Oseltamivir, Amantadine, and Zanamivir. Meijer, Wouter J.; Kromdijk, Wiete; van den Broek, Marcel P. H.; Haas, Pieter-Jan A.; Minnema, Monique C.; Boucher, Charles A.; de Lange, Dylan W.; Wensing, Annemarie M. J. // Case Reports in Infectious Diseases;8/9/2015, Vol. 2015, p1 

    Immunocompromised patients are at increased risk of complications of influenza virus infection. We report on two critically ill patients on immunosuppressive medication with influenza pneumonia. In both patients, oseltamivir monotherapy did not result in clearance of the virus after 18 and five...

  • Anti-viral drugs in flu: not that good?  // Archives of Disease in Childhood;Aug2014, Vol. 99 Issue 8, p766 

    The article focuses on a research related to the administration of antiviral drugs in H1N1 swine flu. Topics discussed include controversies related to the usage of antiviral neuraminidase inhibitors in 2009, the impact of the antiviral drug oseltamivir in flu and research regarding the...

  • Correction: Oseltamivir Compared With Chinese Traditional Therapy.  // Annals of Internal Medicine;1/3/2012, Vol. 156 Issue 1, p71 

    A correction to the article "Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: A randomized trial" that was published in the 2011 issue is presented.

  • Oseltamivir for the treatment of H1N1 influenza during pregnancy. Beigi, RH; Pillai, VC; Venkataramanan, R; Caritis, SN // Clinical Pharmacology & Therapeutics;Oct2015, Vol. 98 Issue 4, p403 

    Pregnancy heightens the risk of adverse outcomes from influenza infections. This is true for both seasonal epidemics as well as occasional pandemics. Seasonal influenza vaccines are the focus of disease prevention and are recommended for all pregnant women in any trimester of pregnancy and...

  • Resistant swine flu found.  // Pulse;11/18/2009, Vol. 69 Issue 37, p19 

    The article reports on the study conducted by Canadian researchers on the resistant strain of H1N1 virus. It is stated that the study found that the first case of Tamiflu-resistant swine flu developing in a young boy who was given prophylaxis. It notes that a single amino acid mutation of the...

  • Structural and Functional Analysis of Laninamivir and its Octanoate Prodrug Reveals Group Specific Mechanisms for Influenza NA Inhibition. Vavricka, Christopher J.; Qing Li; Wu, Yan; Qi, Jianxun; Wang, Mingyang; Liu, Yue; Gao, Feng; Liu, Jun; Feng, Enguang; He, Jianhua; Wang, Jinfang; Liu, Hong; Jiang, Hualiang; Gao, George F. // PLoS Pathogens;Oct2011, Vol. 7 Issue 10, Special section p1 

    The 2009 H1N1 influenza pandemic (pH1N1) led to record sales of neuraminidase (NA) inhibitors, which has contributed significantly to the recent increase in oseltamivir-resistant viruses. Therefore, development and careful evaluation of novel NA inhibitors is of great interest. Recently, a...

  • H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis. Van Der Vries, Erhard; Collins, Patrick J.; Vachieri, Sebastien G.; Xiaoli Xiong; Junfeng Liu; Walker, Philip A.; Haire, Lesley F.; Hay, Alan J.; Schutten, Martin; Osterhaus, Albert D. M. E.; Martin, Steve R.; Boucher, Charles A. B.; Skehel, John J.; Gamblin, Steve J. // PLoS Pathogens;Sep2012, Vol. 8 Issue 9, Special section p1 

    Two classes of antiviral drugs, neuraminidase inhibitors and adamantanes, are approved for prophylaxis and therapy against influenza virus infections. A major concern is that antiviral resistant viruses emerge and spread in the human population. The 2009 pandemic H1N1 virus is already resistant...

  • In silico analysis of drug-resistant mutant of neuraminidase (N294S) against oseltamivir. Karthick, V.; Shanthi, V.; Rajasekaran, R.; Ramanathan, K. // Protoplasma;Feb2013, Vol. 250 Issue 1, p197 

    The recent H1N1 influenza pandemic has attracted worldwide attention due to the high infection rate. Oseltamivir is a new class of anti-viral agent approved for the treatment and prevention of influenza infections. The principal target for this drug is a virus surface glycoprotein, neuraminidase...

  • In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.  // BMC Research Notes;2012, Vol. 5 Issue 1, p105 

    The article presents a study on the in-silico screening of pleconaril and its novel substituted derivatives, with neuraminidase (NA) of H1N1 influenza strain. Neuraminidase refers to a prominent surface antigen of influenza viruses, that aids in the release of viruses from the host cells after...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics